Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Upper limb motor rehabilitation impacts white matter microstructure in multiple sclerosis.
Sphingosine 1-phosphate receptor 1 agonists: a patent review (2013-2015).
Vasomotor reactivity comparison in multiple sclerosis patients with white matter lesions and nonmultiple sclerosis subjects with white matter lesions in brain magnetic resonance imaging.
Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus.
Short-term safety of pulse steroid therapy in multiple sclerosis relapses.
Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis.
Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosis.
Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.
Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.
You're the Flight Surgeon.
Development of a nanomaterial bio-screening platform for neurological applications.
CNS inflammation other than multiple sclerosis: How likely is diagnosis?
An initial validation of the Italian Mishel Uncertainty Illness Scale (MUIS) for relapsing remitting multiple sclerosis patients.
FTY720 induces apoptosis of m2 subtype acute myeloid leukemia cells by targeting sphingolipid metabolism and increasing endogenous ceramide levels.
Use of Functional Ambulation Performance Score as measurement of gait ability: Review.
Morning serum melatonin values in multiple sclerosis: A biochemical evaluation.
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.
When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists.
Multiple sclerosis decreases explicit counterfactual processing and risk taking in decision making.
Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D.
Oligoclonal band status in scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.
Ulcerative Colitis and Perfluorooctanoic Acid (PFOA) in a Highly Exposed Population of Community Residents and Workers in the Mid-Ohio Valley.
Involvement of MicroRNA in Microglia-Mediated Immune Response.
Acute Disseminated Encephalomyelitis (ADEM)-A Rare Complication of Falciparum Malaria.
POLG mutations associated with remitting/relapsing neurological events.
Pages
« first
‹ previous
…
407
408
409
410
411
412
413
414
415
…
next ›
last »